RAPT

RAPT Therapeutics, Inc. - Common Stock (RAPT)

About RAPT Therapeutics, Inc. - Common Stock (RAPT)

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.

Details

Daily high

$8.76

Daily low

$8.35

Price at open

$8.44

52 Week High

$30.60

52 Week Low

$5.67

Market cap

139.9M

Dividend yield

0.00%

Volume

38,798

Avg. volume

115,036

P/E ratio

-.44

RAPT Therapeutics, Inc. - Common Stock News